alb a zine

25
Veterinary Drugs  Product and NADA/ANADA Number Trade Name Ingredients Albendazole 110-048 Valbazen; Albendazole 128-070 VALBAZEN; Albendazole 140-934 VALBAZEN® Albendazole  Back to TOC API Locator: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Home | Drug Thesaurus | Veterinary Master Files | API Search | Services | Site Map Summary of FDA Information: Approval Date: November 10, 1994 Freedom of Information Summary NADA 140-934 I. GENERAL INFORMATION: NADA 140-934 Sponsor: SmithKline Beecham Animal Health 1600 Paoli Pike West Chester, PA 19380 Generic Name: Albendazole Trade Name: VALBAZEN® Marketing Status: OTC II. INDICATIONS FOR USE

Upload: akbar-hossain

Post on 06-Apr-2018

236 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 1/25

Veterinary Drugs

 Product and

NADA/ANADA NumberTrade Name Ingredients

Albendazole

110-048Valbazen; Albendazole

128-070VALBAZEN; Albendazole

140-934VALBAZEN® Albendazole

 

Back to TOC

API Locator: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z 

Home | Drug Thesaurus | Veterinary Master Files | API Search | Services | Site Map

Summary of

FDA Information:

Approval Date: November 10, 1994

Freedom of Information Summary

NADA 140-934

I. GENERAL INFORMATION:

NADA 140-934

Sponsor: SmithKline Beecham Animal Health

1600 Paoli Pike

West Chester, PA 19380

Generic Name: Albendazole

Trade Name: VALBAZEN®

Marketing Status: OTC

II. INDICATIONS FOR USE

Page 2: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 2/25

For the removal andcontrol of the following endoparasites infecting sheep:

A. Liver flukes:

Fasciola hepatica, Fascioloides magna(adults)

B. Tapeworms: Common tapeworms: Moniezia expansa

Fringed tapeworms: Thysanosoma actinioides(heads andsegments)

C. Lungworms:

Dictyocaulus filaria(adults and4th stage larvae)

D. Stomach worms: Barberpole worms: Haemonchus contortus (adults and4th stage larvae)

Brown stomach worms: Ostertagia circumcincta, Marshallagia marshalli(adults and4th stage larvae)

Small stomach worms: Trichostrongylus axei(adults and4th stage larvae)

E. Intestinal worms: Thread-necked intestinal worms: Nematodirus spathiger, N. filicollis(adults and4th stage larvae)

Cooper's worms: Cooperia oncophora (adults and4th stage larvae)

Bankrupt worms: T. colubriformis (adults and

4th stage larvae)

Nodular worms: Oesophagostomum columbianum(adults and4th stage larvae)

Large-Mouth Bowel Worms: Chabertia ovina(adults and4th stage larvae)

III. DOSAGE

A. DOSAGE FORM Suspension 4.55% (45.5 mg/mL)

B. ROUTE OF ADMINISTRATION Oral

C. RECOMMENDED DOSAGES: Seven andone-half (7.5) mg of albendazole per kg of body weight (3.4 mg/lb) administered orally with a suitable syringe ordosing gun.

IV. EFFECTIVENESS

This NADA relies on adequate well-controlled studies demonstrating the anthelmintic effectiveness of albendazole in cattle included in approved NADA 110-048 (Albendazole Suspension, 54 FR 25114, June 13, 1989) and

Page 3: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 3/25

NADA 128-070 (Albendazole Paste, 54 FR 51385, November 17, 1989).

In these studies, thecattle wereeither experimentally ornaturally infected with one or

more species of nematodes, cestodes and

 /or trematodes.The claim foreach major parasitic species is supported by adequate andwell-controlled studies.

Arithmetic means werecalculated to determine efficacy andefficacy wasexpressed in percent removal of worms as compared to controls.The percent reduction wascalculated as follows:

Arithmetic mean no. parasites in control animals

Percentage minus

Reduction of = Arithmetic mean no. parasites in treated animals X 100

Parasites ________________________________________________

Arithmetic mean no. parasites in control animals

As a product foruse in sheep, albendazole qualifies forreview underthe "Minor Use Drug Program." NADA 110-048 (oral suspension) and

NADA 128-070 (oral paste) serve as representative formulations approved foruse in a major species (cattle). Since there wereno drugs approved fortreatment of liver fluke infections, albendazole wasmade available fortreatment of cattle and

sheep from1980 to 1985 on an emergency investigational new animal drug basis in thestates where liver fluke disease prevailed.

Developmental research in sheep wasconducted in nine pivotal studies consisting of six dose-titration andthree dose-confirmation efficacy trials in four different geographic locations in the

United States as well as internationally. Doses ranging from2.5 to 15 mg albendazole per kg body weight, weregiven orally.The results fromthese studies wereused to determine the most effective dose.A dose of 

7.5 mg/kg waseffective against the greatest number of parasite species infecting sheep.

Albendazole, in a suspension formulation, was

Page 4: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 4/25

administered orally as a drench, and

was evaluated forefficacy using the controlled test, as recommended by the Center forVeterinary Medicine in its "Guidelines forEvaluation of Bovine Anthelmintics," which

serves as a guide forall ruminant species. Briefly stated, a certain number of 

infected sheep remain untreated; the remainder receive medication. After a suitable period of time post-treatment (usually 5 to 7 days, but longer in some circumstances), treated anduntreated (control) animals are killed andnecropsied. Remaining parasites are identified andcounted foreach animal.

Albendazole waseffective foreach parasite claimed.The studyconducted against the deer fluke, Fascioloides magnademonstrated 57% efficacy. Albendazole will become the onlyapproved therapy forthis highly pathogenic parasite in sheep.

The results frommajor controlled efficacy studies supported the conclusion that whengiven orally to sheep at 7.5 mg/kg body weight, albendazole is an effective anthelmintic with a wide spectrum of activity against adult andlarval stages of gastrointestinal roundworms, lungworms, tapeworms andliver flukes infecting sheep.The investigators andefficacy against individual parasitic species are given in Tables I, II, III andIV.

(Eds. note: The following table consists of 3 columns.)

Table I

SUMMARY OF PIVOTAL DOSE-TITRATION STUDIES

Efficacy of Albendazole Against Adult Parasites

Parasite % Removal Investigator

(Range)

F. magna 22-64 Stromberg

5.0-15.0 mg/kg

F. hepatica 94-99 Gurnell

5.0-15.0 mg/kg

M. expansa 100 Theodorides

10.0-15.0 mg/kg

Page 5: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 5/25

T. actinioides 54-98 Craig

3.8-7.5 mg/kg

D. filaria 51-94 Theodorides

2.5-10.0 mg/kg

H. contortus 85-99 Craig

3.8-10.0 mg/kg Theodorides

T. axei 100 Craig

3.8-10.0 mg/kg

N. spathiger 94-99 Theodorides

2.5-10.0 mg/kg

(Eds. note: The following table consists of 3 columns.)

Table II

SUMMARY OF PIVOTAL DOSE-TITRATION STUDIES

Efficacy of Albendazole Against Fourth-Stage

Nematode Larvae

Parasite %Removal Investigator

(Range)

D. filaria 89-96 van Schalkwyk

3.8-7.6 mg/kg

O. circumcincta 99-100 Gurnell

5.0-10.0

Oe. columbianum 94-100 Gurnell

5.0-10.0 mg/kg

N. spathiger 100 Gurnell

5.0-10.0 mg/kg

(Eds. note: The following table consists of 3 columns.)

Page 6: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 6/25

Table III

SUMMARY OF PIVOTAL DOSE-CONFIRMATION STUDIES

Efficacy of 

Albendazole Against Trematodes, Cestodes and

Adult Nematodes

Parasite (dose) % Removal Investigator

(Range)

F. hepatica 83-86 Johns

4.75 mg/kg

T. actinioides 100 Bergstrom

7.5 mg/kg

H. contortus 100 Craig

7.5 mg/kg

T. axei 100 Craig

7.5 mg/kg

(Eds. note: The following table consists of 3 columns.)

Table IV

SUMMARY OF DOSE-CONFIRMATION STUDIES

Efficacy of Albendazole Against Fourth-Stage

Nematode Larvae

Parasite % Removal Investigator

(Range)

H. contortus 100 Craig

7.5 mg/kg

Location of Investigators in Tables I, II, III andIV Dr. R. C. Bergstrom, Laramie, WY.

Dr. T. M. Craig, College Station, TX.

Dr. T. O. Gurnell, Terenure, South Africa

Page 7: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 7/25

Dr. D. R. Johns, New South Wales, Australia

Dr. B. E. Stromberg, St. Paul, MN.

Dr. V. J.

Theodorides, West Chester, PA.

Dr. P. C. van Schalkwyk, Terenure, South Africa

A. Dose Titration

Pivotal dose-titration studies werecarried out to determine the dose of albendazole needed to control trematodes, cestodes, gastrointestinal andpulmonary nematodes. Approximately 170 sheep wereused, three-fourths of 

whichweretreated with albendazole.The remaining sheep served as untreated controls. An oral suspension formulation wasutilized with dosages ranging from

2.5 to 15 mg/kg. Accepted husbandry practices wereduplicated with respect to breeds of sheep, diets, and

grazing conditions. Standard procedures werefollowed forallocating, dosing, collecting samples, enumerating andidentifying parasites, and

performing necropsies.The parasitic infections wereexperimentally induced in four (4) of 

the trials andnaturally acquired in theremaining two (2) trials. Based on the data collected, an optimum effective dose of 7.5 mg albendazole per kg body weight wasdetermined.

1) Dose-Titration Study, No.A -8008-75

T. O. Gurnell

Terenure Research Farm

Isando, South Africa

A total of 

46 lambs wasexperimentally infected with metacercariae of F. hepaticaand divided intofive groups.

The controls andthe first three treatment groups werealso experimentally infected with larvae of O. circumcincta, N. spathiger andOe. columbianum. One group of nine lambs remained untreated andserved as a control.The remaining four groups received albendazole suspension as a single oral dose of 

Page 8: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 8/25

5.0, 7.5, 10.0 or15.0 mg/kg (8, 11, 11 and7 lambs, respectively). Ten days after treatment the animals werenecropsied.The percent removal in thetreatment groups is given below. No adverse reaction wasreported.

(Eds. note: The following table consists of 5 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 5.0 7.5 10.0 15.0

mg/kg mg/kg mg/kg mg/kg

F. hepatica (adult) 94 97 98 99

O. circumcincta (larvae) 100 99 99 --

N. spathiger (larvae) 100 100 100 --

Oe. columbianum (larvae) 98 95 99 --

2) Dose-Titration Study, No.A -5180-82A-5180-82 B. E. Stromberg

University of Minnesota

St. Paul, Minnesota

Thirty lambs wereexperimentally infected with metacercariae of F. magnaand divided intofive groups of six. Albendazole will become the only approved therapy forthis highly pathogenic parasite in sheep. Four of the groups received a single oral dose of albendazole suspension at 5.0, 7.5, 10.0 or15.0 mg/kg.The remaining group remained untreated andserved as a control. All animals werenecropsied six weeks after treatment andthe percent removal as listed below wasrecorded. No adverse reaction wasreported.

(Eds. note: The following table consists of 5 columns.)

Percentage Reduction Relative to Controls

Page 9: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 9/25

Albendazole

Parasite 5.0 7.5 10.0 15.0

mg/kg mg/kg mg/kg mg/kg

F. magna (adult) 22 57 64 64

3) Dose-Titration Study, No.A -374-78 T. M. Craig

Texas A&M University

College Station, Texas

Thirty lambs harboring natural infections of T. actinioides, H. contortusand T. axeiwere divided intothree equal groups. Two of the groups weretreated with a single oral dose of 

albendazole suspension at 3.8 or7.5 mg/kg.The third group remained untreated andserved as a control. At necropsy, thefollowing results wererecorded. No adverse reaction wasreported.

(Eds. note: The following table consists of 3 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 3.8 7.5

mg/kg mg/kg

H. contortus (adult) 85 99

T. axei (adult) 100 100

T. actinioides (adult) 54 98

4) Dose-Titration Study, No.

A -206-74 V. J.Theodorides

Applebrook Center

West Chester, Pennsylvania

A total of 23 lambs wasexperimentally infected with H. contortus, N. spathiger,and D. filariaand divided into

Page 10: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 10/25

four groups. One group of five lambs remained untreated, theother groups of six lambs each received a single oral dose of albendazole suspension at 2.5, 5.0, or10.0 mg/kg. At necropsy, thefollowing results were

reported. No adverse reaction wasreported.

(Eds. note: The following table consists of 4 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 2.5 5.0 10.0

mg/kg mg/kg mg/kg

H. contortus (adult) 96 99 99

N. spathiger (adult) 94 95 99

D. filaria (adult) 51 83 94

5) Dose-Titration Study, No. Study A-208-74 V. J.Theodorides

Applebrook Center

West Chester, Pennsylvania

Twelve lambs, naturally infected with M. expansa, weredivided intothree groups of 

four animals each. One group served as an untreated control andthe remaining two groups received a single oral dose of albendazole suspension at either 10 or15 mg/kg. Seven days later the animals werenecropsied.The percent removal in thetreatment groups is given below. No adverse reaction wasreported.

(Eds. note: The following table consists of 3 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 10 mg/kg 15 mg/kg

M. expansa (adult) 100 100

6)Dose-Titration Study, N0.

Page 11: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 11/25

A -8008-77 P. C. van Schalkwyk

Terenure Research Farm

Isando, South Africa

A total of 31 lambs, experimentally infected with Oe. columbianumand D. filarialarvae, wasdivided intothree groups. Two of the groups received albendazole suspension as a single oral dose of 3.8 or7.6 mg/kg (11 lambs each).The third group of nine lambs remained untreated andserved as a control.The following results werereported at necropsy. No adverse reaction wasreported.

(Eds. note: The following table consists of 

3 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 3.8 mg/kg 7.6 mg/kg

Oe. columbianum (larvae) 84 88

D. filaria (larvae) 89 96

Doses ranging from2.5 to 15 mg albendazole per kg body weight, were

given orally.The results fromthese studies wereused to determine the most effective dose.A dose of 

7.5 mg/kg wasselected as the most effective level against the greatest number of parasite species infecting sheep. Albendazole will become the only approved therapy forthis highly pathogenic parasite in sheep. B. Dose-Confirmation

Confirmation of the dose selected forgastrointestinal andpulmonary nematodes, trematodes, and

cestodes was

ascertained in three pivotal controlled trials.A total of 47 sheep wasused, approximately one-half of 

whichweretreated with albendazole; the remaining sheep served as untreated controls. Infections wereacquired naturally in two (2) trials andwereexperimentally induced in theother trial. All of the sheep were

Page 12: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 12/25

necropsied andparasites remaining wererecovered.

1) Dose-Confirmation Study, No.A -8211-76

D. R. Johns

SmithKline Research Station

Cobbitty, New South Wales

Australia.

Twenty lambs wereexperimentally infected with F. hepaticametacercariae anddivided intotwo groups. One group of eleven sheep received a single oral dose of 

albendazole suspension at 4.75 mg/kg; the other group of nine sheep wasleft untreated andserved as a control. At necropsy, thepercent removal of the worms wasrecorded andis given below. No adverse reaction wasobserved.

(Eds. note: The following table consists of 2 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 4.75 mg/kg

F. hepatica (adult) 83

2) Dose-Confirmation Study, No. Study A-368-78 T. M. Craig

Texas A&M University

College Station, Texas

Seven lambs, naturally infected with H. contortus, were

divided into

two groups. One group of three animals received a single oral 7.5 mg/kg dose of albendazole; the remaining four animals wereleft untreated andserved as controls. At necropsy, theresults wereas follows. No adverse reaction wasreported.

(Eds. note: The following table consists of 

Page 13: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 13/25

2 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 7.5 mg/kg

H. contortus (adult) 100

H. contortus (larvae) 99

T. axei (adult) 100

C. oncophora (adult) 100

N. spathiger (adult) 100

3) Dose-Confirmation Study, No.

A -294-77 R. C. Bergstrom

University of Wyoming

Laramie, Wyoming

Twenty sheep, naturally infected with the fringe tapeworm (T. actinioides) weredivided intotwo equal groups. One group received a single oral 7.5 mg/kg dose of albendazole suspension.The other group remained untreated andserved as a control. At necropsy, 21 days after treatment, theresults wereas follows. No adverse reaction was

reported.

(Eds. note: The following table consists of 2 columns.)

Percentage Reduction Relative to Controls

Albendazole

Parasite 7.5 mg/kg

T. actinioidies (adult) 100

C. Field Trials Well-documented clinical field trials wereconducted in theUnited States according to an approved protocol whichwasmodified to accommodate the parasite(s) of interest andlocal management conditions. Groups of sheep with at least a moderate worm infection, as determined by egg counts in their feces, wereselected. In one of the trials the same number of animals wastreated with albendazole or

Page 14: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 14/25

was left untreated andserved as controls. In the other four trials, due to the severity of the infection andthe death losses that had occurred, all animals in theflock weretreated with albendazole. Worm eggs in fecal samples werecounted before and

after treatment, and

animals werevisually observed forside effects.

Five investigators studied albendazole suspension in four states. Sheep of various breeds weretreated. Investigators, trial locations andnumbers of animals in these studies are tabulated on the following pages.The results of these clinical field trials confirm the results of the studies indicating elimination orreduction of fecal egg counts in virtually all treated sheep.

The recommended treatment wasfound to be safe andpractical underfield conditions.

Clinical field trials conducted by foreign investigators werealso submitted.They further confirm the efficacy of albendazole against a broad spectrum of gastrointestinal roundworm, lungworm, tapeworm andliver fluke infections in sheep.

(Eds. note: The following table consists of 

8 columns.)

CLINICAL FIELD TRIALS

WITH ALBENDAZOLE SUSPENSION IN SHEEP

United States

Average Average

Total Type of Worm Eggs Worm Eggs

Study# Investigator/ No. of Parasite No. of Before/After No. of 

Before/After

(mg/kg) Location Animals Infection Treated Treatment Controls Treatment

A-370 Dr. R. W. Randall 140 F. hepatica 140 298.0/6.60 -- --/--

(7.5) Bridger, MT

A-5090 Dr. D.E. Worley 150 F. hepatica 150 1020.0/164.0 -- --/--

Page 15: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 15/25

(7.5) Bozeman, MT

A-5108 Dr. H.R. Sherman 100 Tapeworm, 100 >400.0/-- -- --/--

(5.0) Dover, MA G.I. 300.0/<1.0

Nematode

A-5121 Dr. R.W. Fish 70 F. magna 70 * -- --/--

(7.5) Granton, WI --/--

A-5099 Dr. R.B. Wescott 50 Tapeworm, 25 0.4/0.04 25 0.5/0.7

(7.5) Pullman, WA G.I. 109.0/1.0 107.0/140.0

Nematode

*Since worms do not achieve sexual maturity in this host, no eggs were

produced;

death losses prior to treatment were20-40%, no deaths occurred post-treatment.

V. ANIMAL SAFETY

Studies to evaluate the safety of albendazole in sheep wereconducted at SmithKline Animal Health Products in West Chester, Pennsylvania; French's Forest, Brookvale, Australia;andIsando, Transvaal, South Africa, as well as in thelaboratories of independent investigators in theUnited States and

other countries.

Acute Oral Toxicity Study of Albendazole in Sheep

Investigator:

D. R. Johns

SmithKline Animal Health Products

Cobbitty, New South Wales,

Australia

A-77/3

Purpose:

The objective of this studywas to determine the maximum tolerated dose of 

Page 16: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 16/25

albendazole in sheep.

Methods:

Sixteen Merino sheep were

divided into

four equal groups andreceived a single oral dose of 26.5 (3.5x), 37.5 (5.0x), 53.0 (7.1x) or75.0 (10.0x) mg/kg of albendazole suspension. After administration of the compound, all animals wereobserved daily forclinical signs fora 14-day period.

Results:

All animals in the75 mg/kg group had diarrhea at Day 7.Three of 

the four animals in thegroup had wool break and1 animal died by Day 14. In the 53 mg/kg group, 1 animal exhibited diarrhea. No adverse effects wereobserved in the37.5 or26.5 mg/kg groups.

Conclusion:

The maximum tolerated dose in this study

was 37.5 mg/kg (5X recommended dose).

Acute Oral Toxicity Study of Albendazole in Sheep

Investigator:

P. C. Van Schalkwyk

SmithKline Animal Health Products

Isando, South Africa

Study A-76/2

Purpose:

The objective of this study

was to determine the maximum tolerated dose of albendazole, defined here as that dose at whichno observable clinical symptoms orgross pathology are noted during a 14 day period, in sheep.

Methods:

Twenty Merino male andfemale lambs weighing 18.5 - 43 kg wereassigned to five groups of four lambs each. Albendazole suspension was

Page 17: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 17/25

administered as a single oral dose of 26.5 (3.5x), 37.5 (5.0x), 53.0 (7.1x) or75.0 910.0x) mg/kg.A similar group of four lambs received the suspension vehicle andserved as an untreated control. After administration of the compound, the

animals wereobserved daily for

14 days, then euthanized andnecropsied.

Results:

No adverse sign wasobserved in thetwo lower dose groups. In the two higher dose groups, two of the four animals in each group had appetite depression anddecreased activity. One female in thehighest dose group had slight wool break. No pathogenic change attributable to administration of albendazole wasseen in any of 

the animals.

Conclusion:

The maximum tolerated dose in this studywas 37.5 mg/kg (5X recommended dose).

Evaluation of the Safety of Albendazole When Administered Orally to Ewes During Early Pregnancy

Investigator:

J.M. Tesh

G.A. Harper

Life Science Research

Essex, England

Study 77/SAF20/205/UK

Purpose:

The objective of this studywas to examine the effects of 

albendazole on the progress andoutcome of pregnancy in sheep whenadministered as a single dose on Day 17 of gestation.

Methods:

Approximately 360 Dorset Horn Cross andClun ewes weremated naturally. After mating, the

Page 18: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 18/25

ewes wererandomly assigned to one of five groups.There wasa control group andfour treatment groups receiving a single dose of albendazole at 7.5 mg/kg, 10 mg/kg, 15 mg/kg, or

20 mg/kg 17 days after mating.The numbers of 

lambs born, mortality rates fromthe neonatal period through slaughter, initial lamb examination (bodyweight, general condition, viability estimation, external malformations), lamb index, viability index, mean litter size, livebirth, and

lamb birth weights wererecorded. Maternal factors werepregnancy rate, gestation length, and

parturition difficulties.

Page 19: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 19/25

Albendazole

The Elephant Formulary© 2003-06 Susan K. Mikota DVM and Donald C. Plumb, Pharm.D.Published by Elephant Care International - www.elephantcare.org

Elephant specific information, if available, is in blue.

Chemistry - A benzimidazole anthelmintic structurally related to mebendazole,albendazole has a molecular weight of 265. It is insoluble in water and soluble in alcohol. Storage/Stability/Compatibility- Albendazole suspension should be stored at roomtemperature(15-30°C); avoid freezing. Shake well before using. Uses/Indications - Albendazole is approved for the following endoparasites of cattle:Ostertagia ostertagi , Haemonchus spp., Trichostrongylus spp., Nematodius spp.,Cooperia spp., Bunostomum phlebotomum, Oesphagostomum spp., Dictacaulus spp.,

Fasciola hepatica (adults), and Moniezia spp. It is also used in sheep, goats and swinefor endoparasite control. In cats, albendazole has been used to treat Paragonimus kellicotti infections. In dogsand cats, albendazole has been used to treat capillariasis. In dogs, albendazole hasbeen used to treat Filaroides infections. Albendazole was implicated as being an oncogen in 1984, but subsequent studies wereunable to demonstrate any oncogenic or carcinogenic activity of the drug. Pharmacokinetics - Pharmacokinetic data for albendazole in cattle, dogs and cats werenot located. The drug is thought to be better absorbed orally than other benzimidazoles.

Approximately 47% of an oral dose was recovered (as metabolites) in the urine over a 9day period. After oral dosing in sheep, the parent compound was either not detectable or onlytransiently detectable in the plasma due to a very rapid first-pass effect. The activemetabolites, albendazole sulphoxide and albendazole sulfone reached peak plasmaconcentrations 20 hours after dosing. Contraindications/Precautions - The drug is not approved for use in lactating dairycattle. The manufacturer recommends not administering to female cattle during the first45 days of pregnancy or for 45 days after removal of bulls. Albendazole has beenassociated with teratogenic and embryotoxic effects in rats, rabbits and sheep when

given early in pregnancy. In humans, albendazole is recommended to be used with caution in patients with liver or hematologic diseases. Adverse Effects/Warnings - Albendazole is tolerated without significant adverse effectswhen dosed in cattle at recommended dosages. 

Page 20: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 20/25

Dogs treated at 50 mg/kg twice daily may develop anorexia. Cats may exhibit symptomsof mild lethargy, depression, anorexia, and resistance to taking the medication whenalbendazole is used to treat Paragonimus. Overdosage/Toxicity - Doses of 300 mg/kg (30X recommended) and 200 mg/kg havecaused death in cattle and sheep, respectively. Doses of 45 mg/kg (4.5X) those

recommended did not cause any adverse effects in cattle tested. Cats receiving 100mg/kg/day for 14-21 days showed signs of weight loss, neutropenia and mental dullness. Drug Interactions - In humans, dexamethasone and praziquantal both have beendemonstrated to increase albendazole serum levels. Cimetidine increased albendazolelevels in bile and cystic fluid. Veterinary clinical relevance is unknown. Doses -Cattle:

For susceptible parasites:a) 10 mg/kg PO (Labeled directions; Valbazen® —SKB)b) 7.5 mg/kg PO; 15 mg/kg PO for adult liver flukes. (Roberson 1988b)

c) For adult liver flukes: 10 mg/kg PO; best used in fall when the majority areadults (little or no efficacy against immature forms). A second treatment inwinter may be beneficial. (Herd 1986b)

 Elephants:a) 2.5 mg/kg orally as a single dose (Chandrasekharan, 2002) (Chandrasekharan et.al.,1995), (Chandrasekharan, 1992). Elephant References:a) Chandrasekharan,K. 2002. Specific diseases of Asian elephants. Journal of IndianVeterinary Association Kerala 7:(3):31-34

a) Chandrasekharan,K., Radhakrishnan,K., Cheeran,J.V., Nair,K.N.M., andPrabhakaran,T., 1995. Review of the Incidence, Etiology and Control of CommonDiseases of Asian Elephants with Special Reference to Kerala. In: Daniel,J.C.(Editor), A Week with Elephants; Proceedings of the International Seminar on AsianElephants. Bombay Natural History Society; Oxford University Press, Bombay, India pp.439-449

a) Chandrasekharan,K., 1992. Prevalence of infectious diseases in elephants inKerala and their treatment. In: Silas,E.G., Nair,M.K., and Nirmalan,G. (Editors), TheAsian Elephant: Ecology, Biology, Diseases, Conservation and Management(Proceedings of the National Symposium on the Asian Elephant held at the KeralaAgricultural University, Trichur, India, January 1989). Kerala Agricultural University,

Trichur, India pp. 148-155

Monitoring Parameters -1) Efficacy2) Adverse effects if used in non-approved species or at dosages higher than

recommended. Client Information - Shake well before administering. Contact veterinarian if adverseeffects occur.

Page 21: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 21/25

 Dosage Forms/Preparations/FDA Approval Status - Veterinary-Approved Products:

Albendazole Suspension 113.6 mg/ml (11.36%) in 500 ml, 1 liter, 5 liter Albendazole Paste 205 g (7.2 oz); Valbazen "Valbazen" ® (Pfizer); (OTC) Approved

for use in cattle (not female cattle of breeding age). Slaughter withdrawal=27 days. 

Human-Approved Products:Albendazole Tablets 200 mg Albenza ® "Albenza ®"  (SmithKline Beecham), (Rx)

 

Disclaimer: the information on this page is used entirely at the reader's discretion,and is made available on the express condition that no liability, expressed or implied,

is accepted by the authors or publisher for the accuracy, content, or use thereof.

Page 22: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 22/25

VALBAZEN® SUSPENSION

Pfizer Animal Health

(albendazole)

 Broad-Spectrum Dewormer 

Oral Suspension for Use in Cattle, Sheep, and Goats for removal and control of liver 

 flukes, tapeworms, stomach worms (including 4th stage inhibited larvae of Ostertagia

ostertagi), intestinal worms, and lungworms in cattle and sheep and for the treatment of 

adult liver flukes in nonlactating goats

 NADA #110-048, Approved by FDA

Active Ingredient:

Albendazole 11.36%

(Equivalent to 113.6 mg/mL)

Indications:

Cattle and sheep: Valbazen is a broad-spectrum anthelmintic effective in the removaland control of liver flukes, tapeworms, stomach worms (including 4th stage inhibited

larvae of Ostertagia ostertagi), intestinal worms, and lungworms as indicated below.

Goats: For the treatment of adult liver flukes in nonlactating goats.

Parasite Cattle Sheep Goats

Adult Liver 

Flukes

 Fasciola hepatica Fasciola hepatica , Fascioloides

magna

 Fasciola

hepatica

Heads andSegments of 

Tapeworms

Moniezia benedeni, M.

expansaCommon Tapeworm (Moniezia

expansa), Fringed Tapeworm

(Thysanosoma actinioides)

 

Adult and 4thStage Larvaeof Stomach

Worms

Brown Stomach Worm,including 4th stage inhibitedlarvae (Ostertagia ostertagi),

Barberpole Worm(Haemonchus contortus, H.

 placei), Small Stomach

Worm (Trichostrongylus

Brown Stomach Worm(Ostertagia circumcincta,Marshallagia marshalli),

Barberpole Worm (Haemonchuscontortus), Small Stomach Worm(Trichostrongylus axei)

 

Page 23: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 23/25

axei)

Adult and 4th

Stage Larvae

of Intestinal

Worms

Thread-necked Intestinal

Worm (Nematodirus spathiger , N. helvetianus),

Small Intestinal Worm(Cooperia punctata, C.oncophora)

Thread-necked Intestinal Worm

(Nematodirus spathiger , N. fificollis), Cooper's Worms

(Cooperia oncophora), BankruptWorm (Trichostrongyluscolubriformis), Nodular Worm(Oesophagostomum

columbianum), Large-mouth

Bowel Worm (Chabertia ovina)

 

Adult Stages

of IntestinalWorms

Hookworm (Bunostomum phlebotomum), BankruptWorm (Trichostrongylus

colubriformis), Nodular 

Worm (Oesophagostomum

radiatum)

 

Adult and 4th

Stage Larvae

of 

Lungworms

 Dictyocaulus viviparus  

Adult andLarval Stages

of 

Lungworms

   Dictyocaulus filaria  

Dosage and Administration: Valbazen Suspension should be administered to cattle andgoats at the recommended rate of 4 mL/100 lb of body weight (equivalent to 4.54 mg of albendazole/lb, 10 mg/kg) and to sheep at the recommended rate of 0.75 mL/25 lb of 

 body weight (equivalent to 3.4 mg of albendazole/lb, 7.5 mg/kg). The following table

indicates recommended dosing schedules.

Cattle Sheep Goats

Body Weight Dosage Body Weight Dosage Body Weight Dosage

250 lb 10 mL 25 lb 0.75 mL 25 lb 1 mL

500 lb 20 mL 50 lb 1.5 mL 50 lb 2 mL

750 lb 30 mL 75 lb 2.25 mL 75 lb 3 mL

1000 lb 40 mL 100 lb 3.0 mL 100 lb 4 mL

1250 lb 50 mL 200 lb 6.0 mL 200 lb 5 mL

1500 lb 60 mL 300 lb 9.0 mL 300 lb 6 mL

Page 24: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 24/25

Cattle: 500 mL of Valbazen 11.36% Suspension will treat 25 animals weighing 500 lb. 1

liter of Valbazen 11.36% Suspension will treat 50 animals weighing 500 lb. 5 liters of 

Valbazen 11.36% Suspension will treat 250 animals weighing 500 lb.

Sheep: 500 mL of Valbazen 11.36% Suspension will treat 332 animals weighing 50 lb. 1

liter of Valbazen 11.36% Suspension will treat 664 animals weighing 50 lb. 5 liters of Valbazen 11.36% Suspension will treat 3320 animals weighing 50 lb.

Goats: 500 mL of Valbazen 11.36% Suspension will treat 250 animals weighing 50 lb. 1liter of Valbazen 11.36% Suspension will treat 500 animals weighing 50 lb. 5 liters of 

Valbazen 11.36% Suspension will treat 2500 animals weighing 50 lb.

Valbazen 11.36% Suspension should be given orally using any type of standard dosing

gun or dose syringe.

Important: Accurate estimates of the weight of the cattle, sheep, and goats to be treated

are essential for most effective results with this product. Animals constantly exposed tointernal parasites should be retreated as necessary.

Residue Warnings: Cattle must not be slaughtered within 27 days followinglast treatment. Sheep and Goats must not be slaughtered within 7 days

following last treatment. Because a withdrawal time in milk has not been

established, do not use in female dairy cattle of breeding age. Do not use in

lactating does.

Precaution: Do not administer to female cattle during first 45 days of pregnancy or for 45 days after removal of bulls. Do not administer to ewes during the first 30 days of 

 pregnancy or for 30 days after removal of rams. Consult your veterinarian for assistancein the diagnosis, treatment, and control of parasitism.

Keep This and All Medication Out of Reach of Children

Shake Well Before Using

For Use in Animals Only

Store at Controlled Room Temperature 15°-30°C (59°-86°F)

Protect From Freezing

Not for human use

Restricted Drug (California) - Use only as directed

 Distributed by: Pfizer Animal Health, Div. of Pfizer Inc, NY, NY 10017

Page 25: Alb a Zine

8/3/2019 Alb a Zine

http://slidepdf.com/reader/full/alb-a-zine 25/25

12x500 mL/16.9 fl oz (1 pt 1 fl oz) bottles 8783000 85-8783-07

3x4x1 L/33.8 fl oz (1 qt 1.8 fl oz) bottles 85-8784-06, 8784000 80-8784-08

2x5 L/189 fl oz (1 gal 1 qt 9 fl oz) bottles 85-8785-06, 8785000 80-8785-08